PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich 80802, Germany.\', \'Corporate Health Management / Department Occupational Health; DPDHL Group, Bonn 53113, Germany.\', \'Center for International Health (CIH), University Hospital, LMU Munich, Munich 80336, Germany.\', \'Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich 80802, Germany; German Center for Infection Research (DZIF), Partner Site Munich, Germany; Center for International Health (CIH), University Hospital, LMU Munich, Munich 80336, Germany.\', \'Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich 80802, Germany; German Center for Infection Research (DZIF), Partner Site Munich, Germany. Electronic address: andreas.wieser@lmu.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2352-3964(21)00295-410.1016/j.ebiom.2021.103502
?:hasPublicationType
?:journal
  • EBioMedicine
is ?:pmid of
?:pmid
?:pmid
  • 34333234
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.895
?:rankingScore_hIndex
  • 26
?:title
  • A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all